TAYLOR ASH: Open Payments
NPI 1669107082 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,696 in 153 payments from 11 companies in 2025. Trend: 2023 $2,078 · 2024 $2,532 · 2025 $3,696
Food & beverage: $3,676Education: $20
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 72 | $1,351 |
| ABBVIE INC. | 40 | $1,000 |
| Phathom Pharmaceuticals, Inc. | 9 | $323 |
| Janssen Biotech, Inc. | 4 | $299 |
| Gilead Sciences, Inc. | 2 | $250 |
| Madrigal Pharmaceuticals | 2 | $186 |
| Ardelyx, Inc. | 18 | $175 |
| Ipsen Biopharmaceuticals, Inc | 3 | $63 |
| QOL Medical, LLC | 1 | $22 |
| PFIZER INC. | 1 | $14 |
Products named: XIFAXAN, RINVOQ, VOQUEZNA, TREMFYA, LINZESS, Livdelzi, MAVYRET, REZDIFFRA.
Industry payments across CA — which companies pay providers there.
